Opioid withdrawal symptoms after neurolytic splanchnic nerve block in cancer patients.

Ryota YanaizumiYusuke NagamineShinsuke HaradaTomoko KuramochiShuhei OtaTakahisa Goto

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

OW was observed in 20.8% of the patients in the study. A longer pain and opioid use duration and a larger opioid tapering dose may predispose patients to OW.

Keyphrases

end stage renal disease
chronic pain
ejection fraction
newly diagnosed
pain management
chronic kidney disease
prognostic factors
spinal cord injury